- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvant Therapy for High-Risk Gastrointestinal Stromal Tumour
Authors
Keywords
-
Journal
DRUGS
Volume 72, Issue 15, Pages 1953-1963
Publisher
Springer Nature
Online
2012-09-22
DOI
10.2165/11635590-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relation of tumor pathologic and molecular features to outcome after surgical resection of localized primary gastrointestinal stromal tumor (GIST): Results of the intergroup phase III trial ACOSOG Z9001.
- (2017) C. L. Corless et al. JOURNAL OF CLINICAL ONCOLOGY
- Follow-up results after 9 years (yrs) of the ongoing, phase II B2222 trial of imatinib mesylate (IM) in patients (pts) with metastatic or unresectable KIT+ gastrointestinal stromal tumors (GIST).
- (2017) M. von Mehren et al. JOURNAL OF CLINICAL ONCOLOGY
- One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor
- (2012) Heikki Joensuu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Natural History of Imatinib-naive GISTs
- (2011) Sabrina Rossi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132
- (2011) Dian Wang et al. ANNALS OF SURGICAL ONCOLOGY
- Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial
- (2011) Aurore Blesius et al. BMC CANCER
- Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes
- (2011) P. Rutkowski et al. EJSO
- Post-operative imatinib in patients with intermediate or high risk gastrointestinal stromal tumor
- (2011) J. Li et al. EJSO
- Response to Imatinib Rechallenge of GIST That Recurs Following Completion of Adjuvant Imatinib Treatment - the First Analysis in the SSGXVIII/AIO Trial Patient Population
- (2011) P. Reichardt et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant and neoadjuvant imatinib therapy: Current role in the management of gastrointestinal stromal tumors
- (2011) Burton L. Eisenberg et al. INTERNATIONAL JOURNAL OF CANCER
- KRAS-Mutation Positive, Metastatic Tonsil Carcinoma With Cancer Stem-Like Cell Features and Long-Term Response to Gefitinib: A Case Report and Review of the Literature
- (2011) Sandra Gottschling et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: A median follow-up of 44 months
- (2011) Wei-Zhong Jiang et al. JOURNAL OF SURGICAL ONCOLOGY
- Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts
- (2011) Heikki Joensuu et al. LANCET ONCOLOGY
- Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs
- (2011) J. F. Emile et al. MEDICAL ONCOLOGY
- Surgical outcomes of gastrointestinal stromal tumors of the stomach: a single unit experience in the era of targeted drug therapy
- (2011) Hai Huang et al. MEDICAL ONCOLOGY
- Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
- (2011) Françoise Ducimetière et al. PLoS One
- Molecular and Clinicopathologic Characterization of Gastrointestinal Stromal Tumors (GISTs) of Small Size
- (2010) Sabrina Rossi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Practical management of tyrosine kinase inhibitor-associated side effects in GIST
- (2010) Heikki Joensuu et al. CANCER TREATMENT REVIEWS
- Kitlow Stem Cells Cause Resistance to Kit/Platelet-Derived Growth Factor α Inhibitors in Murine Gastrointestinal Stromal Tumors
- (2010) Michael R. Bardsley et al. GASTROENTEROLOGY
- Cross-Sectional Study of Imatinib Plasma Trough Levels in Patients With Advanced Gastrointestinal Stromal Tumors: Impact of Gastrointestinal Resection on Exposure to Imatinib
- (2010) Changhoon Yoo et al. JOURNAL OF CLINICAL ONCOLOGY
- Cost effectiveness of tyrosine kinase inhibitor therapy in metastatic gastrointestinal stromal tumors
- (2010) Charles D. Blanke et al. JOURNAL OF MEDICAL ECONOMICS
- An Evaluation of 2537 Gastrointestinal Stromal Tumors for a Proposed Clinical Staging System
- (2009) Charles E. Woodall ARCHIVES OF SURGERY
- Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors
- (2009) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
- (2009) Ronald P DeMatteo et al. LANCET
- Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
- (2009) Jason S Gold et al. LANCET ONCOLOGY
- A Randomized, Phase II Study of Preoperative plus Postoperative Imatinib in GIST: Evidence of Rapid Radiographic Response and Temporal Induction of Tumor Cell Apoptosis
- (2008) John C. McAuliffe et al. ANNALS OF SURGICAL ONCOLOGY
- Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1
- (2008) C. Mussi et al. CLINICAL CANCER RESEARCH
- Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors
- (2008) Narasimhan P. Agaram et al. GENES CHROMOSOMES & CANCER
- Risk stratification of patients diagnosed with gastrointestinal stromal tumor
- (2008) Heikki Joensuu HUMAN PATHOLOGY
- Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT
- (2008) Charles D. Blanke et al. JOURNAL OF CLINICAL ONCOLOGY
- Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity
- (2007) P. J. Perik et al. ANNALS OF ONCOLOGY
- Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST)
- (2007) Ronald P. DeMatteo et al. CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started